Market closed
Establishment Labs/$ESTA
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Establishment Labs
Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing silicone-filled breast and body shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.
Ticker
$ESTA
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Alajuela, Costa Rica
Employees
857
Website
ESTA Metrics
BasicAdvanced
$1.4B
Market cap
-
P/E ratio
-$3.10
EPS
1.24
Beta
-
Dividend rate
Price and volume
Market cap
$1.4B
Beta
1.24
52-week high
$60.12
52-week low
$16.96
Average daily volume
544K
Financial strength
Current ratio
4.443
Quick ratio
2.735
Long term debt to equity
436.973
Total debt to equity
436.973
Interest coverage (TTM)
-3.49%
Management effectiveness
Return on assets (TTM)
-13.44%
Return on equity (TTM)
-166.58%
Valuation
Price to revenue (TTM)
8.665
Price to book
30.26
Price to tangible book (TTM)
39.47
Price to free cash flow (TTM)
-15.037
Growth
Revenue change (TTM)
-14.56%
Earnings per share change (TTM)
26.46%
3-year revenue growth (CAGR)
10.54%
3-year earnings per share growth (CAGR)
49.20%
What the Analysts think about ESTA
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Establishment Labs stock.
ESTA Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
ESTA Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
ESTA News
AllArticlesVideos
Establishment Labs Announces $50 Million Registered Direct Offering
Business Wire·13 hours ago
Establishment Labs Announces Three-Year Mia Femtech Clinical Results at 9th World Symposium on Ergonomic Implants
Business Wire·1 week ago
Establishment Labs Receives U.S. FDA Approval for Motiva Implants
Business Wire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Establishment Labs stock?
Establishment Labs (ESTA) has a market cap of $1.4B as of November 08, 2024.
What is the P/E ratio for Establishment Labs stock?
The price to earnings (P/E) ratio for Establishment Labs (ESTA) stock is 0 as of November 08, 2024.
Does Establishment Labs stock pay dividends?
No, Establishment Labs (ESTA) stock does not pay dividends to its shareholders as of November 08, 2024.
When is the next Establishment Labs dividend payment date?
Establishment Labs (ESTA) stock does not pay dividends to its shareholders.
What is the beta indicator for Establishment Labs?
Establishment Labs (ESTA) has a beta rating of 1.24. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.